We are pleased to announce the appointment of William S. Marth to our Board of Directors. His understanding of the industry is pivotal in ensuring a successful commercial implementation of our technology and makes him an ideal addition to our leadership
https://t.co/IPt8BiuvcA
Targeting Particle Size Specification in Pharmaceutical Crystallization. A new Review by Liu, Mascia & colleagues at Soochow University and CONTINUUS Pharmaceuticals @ContinuusP explains how to stay in control from a perspective of process parameters. https://t.co/5xHpq1yBvZ
Hear Bayan Takizawa, MD, MBA of @ContinuusP; Steven Gravallese of @Cytiva; Dr. Fernando J. Muzzio of @RutgersU; and Daniel Blackwood of @pfizer discuss the advances & advantages of continuous manufacturing. Watch this year’s Technical Conference sessions: https://t.co/gYhImKXVcM
Dr Chuntian Hu from Continuous Pharmaceuticals closing our 4th flow chemistry and continuous processing conference with a presentation on reactor design and selection for continuous manufacture of pharmaceuticals #FLOWNA22
@ContinuusP, an innovator in transforming the production of small-molecule pharmaceuticals, is expanding with a new cGMP Manufacturing Facility in Woburn (a #ReadyMass100 property). @SkanskaUSA was awarded a $125 million contract to complete the project https://t.co/IPv3biKkJh
We are looking forward to joining many peers and colleagues at the 6th Commercializing Continuous Processing (CCP) Summit in March. You can find out more about the event on the website here https://t.co/XWdyhDXONr including further details on an exciting site visit to CONTINUUS
#Travel requirements for all passengers traveling to the United States by air have changed, including requirements for #COVID19 testing and vaccination. Learn more about the new requirements: https://t.co/lLA0KG4QNX. #CDC
Congrats to Sal Mascia & the team at @ContinuusP! This Woburn company was one of the 71 awardees honored at this year’s MA Manufacturing Awards at @PolarPark for manufacturing excellence. Thank you to @jeffrpy, @EricLesser, & the MA Legislative Manufacturing Caucus for hosting.
We have a new lab for high potency drugs using our proprietary Integrated Continuous Manufacturing! Our #continuousmanufacturing tech enables #biopharma companies to expedite delivery of on-demand, affordable and high-quality small molecule medicines.
https://t.co/rn5C9tu4d1
We assembled a world-class advisory team to ensure successful completion of our ICM Factory Project: Moheb Nasr (Reg.), Franco Pieropan (Qual./Compl.), Jim Powers (Qual. Sys.), Steve Dreamer (Pharm. Eng.), and Richard Priester (Eng./Const.).
https://t.co/52HuDFpP1P
We are excited to share our latest video! Watch and learn about our company and our mission to delivered high-quality drugs to patients more effectively and at a lower cost.
https://t.co/7DC7aB7gzN
Listen to @SalMascia and @BayanTakizawa on this episode of MedStreet Journal! They discuss the evolution of Pharmaceutical Manufacturing and the benefits of Advanced Manufacturing on patient care and the industry.
https://t.co/c57AJFTvKg
Join us at #BIODigital, June 10-11 & 14-18! You can find our company presentation on demand on the BIO Digital Event Hub! @BIOConvention
https://t.co/djx813GOjL
📌 Live webinar | June 23, 2021 📌
CONTINUUS Pharmaceuticals and IMA Active show the feasibility of Continuous Manufacturing of highly reproducible molded tablets through the EMC (Extrusion-Molding-Coating) machine. Register now:
https://t.co/xq5QLQUioD